Bloxiverz Approval History
- FDA approved: Yes (First approved May 31st, 2013)
- Brand name: Bloxiverz
- Generic name: neostigmine methylsulfate
- Dosage form: Injection
- Company: Flamel Technologies
- Treatment for: Reversal of Nondepolarizing Muscle Relaxants
Bloxiverz (neostigmine methylsulfate) is a cholinesterase inhibitor used for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.
Development History and FDA Approval Process for Bloxiverz
|Jun 3, 2013||Flamel Technologies Announces FDA Approval of Bloxiverz|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.